Read + Share
Amedeo Smart
Independent Medical Education
Gibouin VC, Durand M, Boudesco C, Hermetet F, et al. First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphoma. Leukemia 2024 Jun 21. doi: 10.1038/s41375-024-02302.PMID: 38906964
Email
LinkedIn
Privacy Policy